J3245
HCPCSInj., tildrakizumab, 1 mg
Based on the latest published hospital price files, code J3245 (Inj., tildrakizumab, 1 mg) appears at 4 hospitals with disclosed cash prices from $26,636 to $41,990. This is public hospital price transparency data, not a guaranteed estimate of your bill.
Published-price availability
A blank price (“—”) means a hospital names this service but did not publish a dollar amount — it is not a free service or a $0 price.
Compare J3245 prices
Filter by hospital, city, setting, or payer — the summary and charts update with your filters.
Published cash prices for code J3245 vary by about 58% across the 2 hospitals with disclosed prices here — from $26,636 to $41,990. Shopping around can matter.
Lowest cash price by hospital
- Atrium Health Lincoln$26,636
Cash price by city
Reflects your current filters.
- Lincolnton · 1 hospital$26,636
- Menomonee Falls · 1 hospital$41,990
5 prices shown.
| Service | Hospital | Code | List price | Cash price | Negotiated range | Allowed (median) | |
|---|---|---|---|---|---|---|---|
| Inj., tildrakizumab, 1 mg Outpatient | Endeavor Health Edward Hospital | J3245 HCPCS | — | — | $118 – $343 | — | |
| Ilumya: 1 Ml In 1 Carton (47335-177-95) Inpatient & outpatient | University of Chicago Medical Center | J3245 HCPCS | — | — | — | — | |
| Inj., tildrakizumab, 1 mg Outpatient | University of Chicago Medical Center | J3245 HCPCS | — | — | — | — | |
| tildrakizumab-asmn 100 MG/ML Solution Prefilled Syringe 1 mL Syringe Outpatient | Froedtert Menomonee Falls Hospital | J3245 HCPCS | $76,346 | $41,990 | $127 – $68,712 | — | |
| TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE Outpatient | Atrium Health Lincoln | J3245 HCPCS | $53,271 | $26,636 | $130 – $50,608 | — |
How to read these prices
- Cash price
- The discounted self-pay price for paying directly, without insurance.
- List price
- The hospital’s full undiscounted charge — rarely what anyone pays.
- Negotiated rate
- A rate for a specific insurer and plan; your share depends on your benefits.
- Allowed amount
- A historical reference for what was actually allowed, where disclosed.
Hospitals that publish J3245 prices
Open a hospital to see this code in the context of its full published prices.
Code J3245: frequently asked
- What does code J3245 cost?
- Across the published hospital price files, the disclosed cash price for J3245 ranges from $26,636 to $41,990. This is public hospital price transparency data, not a guaranteed estimate of your bill.
- Will this be my final bill?
- Actual patient responsibility may vary based on your insurance plan, deductible, coinsurance, network status, diagnosis, setting, bundled services, clinical circumstances, and hospital billing practices.
- What is code J3245?
- J3245 is the billing code hospitals use to identify "Inj., tildrakizumab, 1 mg" on their published price files. We use it to line up the same service across different hospitals.
- Why do prices for this code differ between hospitals?
- Each hospital sets its own prices and negotiates separately with each insurer, so the disclosed price for the same code can vary widely from one hospital to another — and even between plans at a single hospital. Comparing the published figures is what this page is for; a difference does not by itself mean one hospital is better or worse.
- What this page is not
- It is not a quote, a guarantee, or medical advice. It shows what hospitals have published for this code, so you can compare and ask informed questions — your actual cost depends on your insurance, the exact services performed, and the care setting.